180976-94-7 Usage
General Description
BOC-4-AMINO-3-METHYLBENZOIC ACID is a chemical compound that belongs to the class of benzoic acid derivatives. It is a white crystalline solid commonly used in organic synthesis and pharmaceutical research. BOC-4-AMINO-3-METHYLBENZOIC ACID contains a BOC (tert-butyloxycarbonyl) protecting group, which is commonly used in peptide synthesis to protect the amine group and prevent unwanted reactions. BOC-4-AMINO-3-METHYLBENZOIC ACID has numerous applications in medicinal chemistry, specifically in the design and synthesis of biologically active molecules and pharmaceuticals. Additionally, it can be used as a building block in the production of various chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 180976-94-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,0,9,7 and 6 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 180976-94:
(8*1)+(7*8)+(6*0)+(5*9)+(4*7)+(3*6)+(2*9)+(1*4)=177
177 % 10 = 7
So 180976-94-7 is a valid CAS Registry Number.
180976-94-7Relevant articles and documents
Inhibitors of prenyl transferases
-
, (2008/06/13)
Compounds which inhibit prenyl transferases, particularly farnysyltransferase and geranylgeranyl transferase I, processes for preparing the compounds, pharmaceutical compositions containing the compounds, and methods of use.
Inhibitors of farnesyltransferase
-
, (2008/06/13)
Peptidomimetics of the formula CβX where C is cysteine, X is any naturally occuring amino acid, and β is a hydrophobic spacer, most notably 2-phenyl-4-aminobenzoic acid. These compounds are effective inhibitors of p2lras farnesyltrasferase, block Ras-dependent oncogenic signalling and inhibit human tumor growth in vivo in animal models. Pro-drugs made by functionalizing terminal amino and carboxylic acid groups of peptides and peptidomimetics are also disclosed. Such functionalized derivatives demonstrate increased cell uptake. Other structural modifications are also disclosed.
